• Email
  • Help

This page brings together the Agency's latest information on HIV and AIDS.

It lists:

  • the ten newest and recently updated medicines authorised for the treatment of HIV and AIDS in the European Union (EU);
  • the most recent opinions on medicines against HIV and AIDS that are pending authorisation by the European Commission (EC);
  • the latest HIV- and AIDS-related news and press releases;
  • the Agency's events on HIV- and AIDS-related topics.



  • 10/11/2015


    Expert meeting on paediatric development of fixed-dose combinations for the treatment of the human immunodeficiency virus (HIV)

    As a requirement of the Paediatric Regulation, all new medicinal products developed for the treatment of HIV-1 infection in adults, must have an agreed paediatric investigation plan (PIP) in place, ensuring the necessary data are obtained to support the medicine's authorisation for use in children, when appropriate. The Paediatric Committee (PDCO) is responsible for agreeing these PIPs. The purpose of this expert meeting is to advise the EMA and the PDCO on the best development pathways for fixed-dose combinations for the treatment of children and adolescents living with HIV. ... Read more